Micronucleus analysis in peripheral blood lymphocytes from melanoma patients treated with dacarbazine

Anticancer Research

Volumn 18, Issue 3 B, 1998, Pages 1967-1971

  Miele, Mariangela ^a   Bonassi, Stefano ^a   Bonatti, Stefania ^a,b   Martini, Elena ^a   Miglio, Luigi ^a   Ottaggio, Laura ^a   Queirolo, Paola ^a   Sertoli, Mario R ^a   Abbondandolo, Angelo ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Dacarbazine; Melanoma; Micronucleus

Indexed keywords

ANTIBODY; DACARBAZINE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CENTROMERE; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; MALE; MELANOMA; MICRONUCLEUS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CHROMOSOME DELETION; DACARBAZINE; FEMALE; HUMANS; LYMPHOCYTES; MALE; MELANOMA; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MIDDLE AGED;

EID: 0031901851     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kingra GS, Comis R, Olson KM and Horton J: 5-(3,3-Dimethyl-1-triazeno) imidazole-4-carboxamide in the treatment of malignant tumors other than melanoma. Cancer Chemother 55: 281-283, 1971.
2. Comis RL: DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep 60: 165-176, 1976.
3. Baich CM, Houghton A and Peters L: Cutaneous melanoma. In: Cancer: Principles and Practice of Oncology (De Vita, V.T., Hellman, S and Rosenberg, SA, eds). Lippincott: Philadelphia, 1989. pp. 1499-1542.
4. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A and Bonadonna G: Second acute leukemia and other malignancies following treatment for Hodgkin's disease. J Clin Oncol 4: 830-837, 1986.
5. Bartoli-Klugmann F, Pani B, Babudri N, Montibragadin C, Tamaro M and Venturini S: In vitro mutagenic activity of 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in eukaryotic and prokaryotic cells. Carcinogenesis 3: 467-471, 1982.
6. Beat DD, Skibba JW, Croft WA, Cohen SM, and Bryan GT: Carcinogenicity of the antineoplastic agent 5-(3,3-dimethyl-1-triazeno)-imidazole-4-carboxamide and its metabolites in rats. J Natl Cancer Inst 54: 951-957, 1975.
7. Skibba JL and Bryan GT: Methylation of nucleic acids and urinary excretion of C-labelled 7-methylguanine by rats and man after administration of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5-(4)-carboxamide. Toxicol Appl Pharmacol 18: 707-719, 1971.
8. Meer L, Janzer RC, Kleihues P and Kolar GF: In vivo metabolism and reaction with DNA of the cytostatic agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC). Biochem Pharmacol 35: 3243-3247, 1986.
9. 6-methylguanine. In: Genetic Toxicology of environmental chemicals. Part A: basic principles and mechanisms of action. (Ramel C, Lambert B and Magnusson J, eds). New York, Alan R Liss, Inc, 1986, pp. 433-440.
10. Matter BE and Schmid W: Trenimon-induced chromosome damage in bone marrow cells of six mammalian species, evaluation of the micronucleus test. Mutat Res 12: 417-425, 1971.
11. von Ledebur M and Schmid W: The micronucleus test. Methodological aspects. Mutat Res 19: 109-117, 1973.
12. Heddle JA. A rapid in vivo test for chromosome damage. Mutat Res 18: 191-197, 1973.
13. Vanparys P, Vermeiren F, Sysmans M and Temmerman R: The micronucleus assay as a test for the detection of aneugenic activity. Mutat Res 244: 95-103, 1990.
14. Merry DE, Pathak S, Hsu TC and Brinkley BR: Anti-kinetochore antibodies: use as probes for inactive centromeres. Am J Hum Genet 37: 425-430, 1985.
15. Countryman PI and Heddle JA: The production of micronuclei from chromosome aberrations in irradiated cultures of human lymphocytes. Mutat Res 41: 321-332, 1976.
16. Nuesse M, Viaggi S and Bonatti S: Induction of kinetochore positive and negative micronuclei in V79 cells by the alkylating agent diethylsulphate. Mutagenesis 4: 174-178, 1989.
17. Whorton EB Jr: Some experimental design and analysis consideration for cytogenetic studies. Environ Mutagenesis 7: 9-15, 1985.
18. Norusis MJ: SPSS for Windows Release 5. SPSS Inc. Chicago: IL. 1992.
19. 6-methylguanine require conversion of the methylated base to a nucleotide. Environm Mol Mutagen 26: 226-23, 1995.
20. Preussman R, Ivankovich S, Landschutz C, Gimmy J, Flohr E and Griesbach U: Carcinogenicity of 13 aryldialkyltriazenes in BD rats. Z Krebsforsch 81: 285-310, 1974.
21. Kolar GF: Carcinogenicity of cytostatic triazenes. In: Carcinogenicity of Alkylating Cytostatic Drugs. (Schmahl D and Kaldor JM eds), IARC Scientific Publication no. 78. Lyon, International Agency for Research on Cancer, 1986, pp. 111-126.
22. Solveig-Wallas SA and Ringborg U: Induction and time course of DNA single-strand breaks in lymphocytes from patients treated with dacarbazine. Carcinogenesis 12: 1153-1154, 1991.
23. 6-methylguanine in human leukocyte DNA after intravenous exposure to dacarbazine. Carcinogenesis 12: 285-288, 1991.
24. Fenech M and Morley AA: Measurement of micronuclei in lymphocytes. Mutat Res 147: 29-36, 1985.
25. Norppa H, Renzi L and Lindholm C: Detection of whole chromosomes in micronuclei of cytokinesis-blocked human lymphocytes by antikinetochore staining and in situ hybridization. Mutagenesis 8: 519-525, 1993.
26. Singer B and Grunberger D: Molecular Biology of Mutagens and Carcinogens. New York, Plenum Press, 1983, pp. 1-347.
27. Shaffil R, Margison GP and O'Connor PJ: Mechanisms of Carcinogenesis induced by alkylating agents. Biochem Biophys Acta 823: 111-145, 1985.
28. Bonatti S and Abbondandolo A: The search for the molecular lesions responsible for the induction of chromosomal damage by alkylating agents. Ann 1st Super Sanità 25: 205-212, 1989.
29. Pegg AE: Alkylation and subsequent repair of DNA after exposure to dimethylnitrosamine and related carcinogens. Rev Biochem Toxicol 5: 83-133, 1983.
30. Demple B and Karran P. Death of an enzyme: suicide repair of DNA. Trend Biol Sci 8: 137-139, 1983.
31. 6-alkylguanine-DNA alkyltransterase depletion and regeneration in human peripheral lymphocytes following dacarbazine and fotemustine. Cancer Res 51: 619-623, 1991.